Terms: = Colorectal cancer AND MTOR, FRAP2, FRAP1, 2475, ENSG00000198793, P42345, RAPT1, RAFT1, FRAP, FLJ44809 AND Treatment
575 results:
1. Cribriform morular thyroid carcinoma: Clinicopathological and molecular basis for both a preventive and therapeutic approach for a rare tumor (Review).
Cameselle-García S; Abdulkader-Nallib I; Sánchez-Ares M; Cameselle-Teijeiro JM
Oncol Rep; 2024 Sep; 52(3):. PubMed ID: 39027989
[TBL] [Abstract] [Full Text] [Related]
2. Dasabuvir alleviates 5-fluorouracil-induced intestinal injury through anti-senescence and anti-inflammatory.
He S; Wang Z; Xia J; Jia H; Dai Q; Chen C; He F; Wang X; Zhou M
Sci Rep; 2024 Jul; 14(1):15730. PubMed ID: 38977864
[TBL] [Abstract] [Full Text] [Related]
3. Interplay between WNT/PI3K-mtor axis and the microbiota in APC-driven colorectal carcinogenesis: data from a pilot study and possible implications for CRC prevention.
Di Paola FJ; Alquati C; Conti G; Calafato G; Turroni S; D'Amico F; Ceccarelli C; Buttitta F; Bernardi A; Cuicchi D; Poggioli G; Turchetti D; Ferrari S; Cannizzaro R; Realdon S; Brigidi P; Ricciardiello L
J Transl Med; 2024 Jul; 22(1):631. PubMed ID: 38970018
[TBL] [Abstract] [Full Text] [Related]
4. Selective PI3Kδ inhibitor TYM-3-98 suppresses AKT/mtor/SREBP1-mediated lipogenesis and promotes ferroptosis in KRAS-mutant colorectal cancer.
Zheng YN; Lou SY; Lu J; Zheng FL; Tang YM; Zhang EJ; Cui SL; Zhao HJ
Cell Death Dis; 2024 Jul; 15(7):474. PubMed ID: 38956060
[TBL] [Abstract] [Full Text] [Related]
5. Comprehensive genomic profiling and therapeutic implications for Taiwanese patients with treatment-naïve breast cancer.
Chen SH; Tse KP; Lu YJ; Chen SJ; Tian YF; Tan KT; Li CF
Cancer Med; 2024 Jun; 13(12):e7384. PubMed ID: 38895905
[TBL] [Abstract] [Full Text] [Related]
6. Targeted treatment against cancer Stem Cells in colorectal cancer.
Martínez-Pérez J; Torrado C; Domínguez-Cejudo MA; Valladares-Ayerbes M
Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892410
[TBL] [Abstract] [Full Text] [Related]
7. Rapamycin circumvents anti PD-1 therapy resistance in colorectal cancer by reducing PD-L1 expression and optimizing the tumor microenvironment.
Jia M; Yuan Z; Yu H; Feng S; Tan X; Long Z; Duan Y; Zhu W; Yan P
Biomed Pharmacother; 2024 Jul; 176():116883. PubMed ID: 38876047
[TBL] [Abstract] [Full Text] [Related]
8. The role of the natural compound naringenin in AMPK-mitochondria modulation and colorectal cancer inhibition.
Wang D; Zhou Y; Hua L; Hu M; Zhu N; Liu Y; Zhou Y
Phytomedicine; 2024 Aug; 131():155786. PubMed ID: 38875812
[TBL] [Abstract] [Full Text] [Related]
9. TBC1D10B promotes tumor progression in colon cancer via PAK4‑mediated promotion of the PI3K/AKT/mtor pathway.
Chi XJ; Song YB; Zhang H; Wei LQ; Gao Y; Miao XJ; Yang ST; Lin CY; Lan D; Zhang X
Apoptosis; 2024 Aug; 29(7-8):1185-1197. PubMed ID: 38824479
[TBL] [Abstract] [Full Text] [Related]
10. Epigenetic regulation of autophagy by non-coding RNAs and exosomal non-coding RNAs in colorectal cancer: A narrative review.
Liu M; Jiang H; Momeni MR
Int J Biol Macromol; 2024 Jul; 273(Pt 2):132732. PubMed ID: 38823748
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic factors and survival disparities in right-sided versus left-sided colon cancer.
Asghari-Jafarabadi M; Wilkins S; Plazzer JP; Yap R; McMurrick PJ
Sci Rep; 2024 May; 14(1):12306. PubMed ID: 38811769
[TBL] [Abstract] [Full Text] [Related]
12. Multiomics-based molecular subtyping based on the commensal microbiome predicts molecular characteristics and the therapeutic response in breast cancer.
Qin W; Li J; Gao N; Kong X; Guo L; Chen Y; Huang L; Chen X; Qi F
Mol Cancer; 2024 May; 23(1):99. PubMed ID: 38730464
[TBL] [Abstract] [Full Text] [Related]
13. Exploring the Key Signaling Pathways and ncRNAs in colorectal cancer.
Lee YJ; Kim WR; Park EG; Lee DH; Kim JM; Shin HJ; Jeong HS; Roh HY; Kim HS
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674135
[TBL] [Abstract] [Full Text] [Related]
14. PI3K/Akt/mtor Signaling Pathway as a Target for colorectal cancer treatment.
Leiphrakpam PD; Are C
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542151
[TBL] [Abstract] [Full Text] [Related]
15. Inhibition of Multifunctional Protein p32/C1QBP Promotes Cytostatic Effects in Colon cancer Cells by Altering Mitogenic Signaling Pathways and Promoting Mitochondrial Damage.
Egusquiza-Alvarez CA; Moreno-Londoño AP; Alvarado-Ortiz E; Ramos-Godínez MDP; Sarabia-Sánchez MA; Castañeda-Patlán MC; Robles-Flores M
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473963
[TBL] [Abstract] [Full Text] [Related]
16. Broccoli extracellular vesicles enhance the therapeutic effects and restore the chemosensitivity of 5-fluorouracil on colon cancer.
Cao Y; Hou L; Li M; Zhang J; Wang L; Liu C; Luo T; Yan L; Zheng L
Food Chem Toxicol; 2024 Apr; 186():114563. PubMed ID: 38442787
[TBL] [Abstract] [Full Text] [Related]
17. Pyrvinium Pamoate Induces Cell Apoptosis and Autophagy in colorectal cancer.
Zheng W; Chen K; Lv Y; Lao W; Zhu H
Anticancer Res; 2024 Mar; 44(3):1193-1199. PubMed ID: 38423653
[TBL] [Abstract] [Full Text] [Related]
18. Selective Synergy of Rapamycin Combined With Methioninase on cancer Cells Compared to Normal Cells.
Ardjmand D; Kubota Y; Sato M; Han Q; Mizuta K; Morinaga S; Hoffman RM
Anticancer Res; 2024 Mar; 44(3):929-933. PubMed ID: 38423628
[TBL] [Abstract] [Full Text] [Related]
19. Phase I study of sapanisertib (CB-228/TAK-228/MLN0128) in combination with ziv-aflibercept in patients with advanced solid tumors.
Coleman N; Stephen B; Fu S; Karp D; Subbiah V; Ahnert JR; Piha-Paul SA; Wright J; Fessahaye SN; Ouyang F; Yilmaz B; Meric-Bernstam F; Naing A
Cancer Med; 2024 Feb; 13(3):e6877. PubMed ID: 38400671
[TBL] [Abstract] [Full Text] [Related]
20. Serotonin Receptor HTR2B Facilitates colorectal cancer Metastasis via CREB1-ZEB1 Axis-Mediated Epithelial-Mesenchymal Transition.
Li T; Wei L; Zhang X; Fu B; Zhou Y; Yang M; Cao M; Chen Y; Tan Y; Shi Y; Wu L; Xuan C; Du Q; Hu R
Mol Cancer Res; 2024 Jun; 22(6):538-554. PubMed ID: 38381131
[TBL] [Abstract] [Full Text] [Related]
[Next]
